NAGENE specializes in the rapid synthesis of custom DNA sequences, utilizing a GMP-compliant, in-house process that ensures high-quality production within an average turnaround time of five days. This capability addresses the urgent need for reliable gene synthesis in pharmaceutical research and development, particularly for mRNA vaccines and cancer treatments.
Funding
Funding not disclosed
Founders
Product
Problem
The demand for custom DNA sequences in pharmaceutical research, particularly for mRNA vaccines and cancer treatments, requires fast turnaround times and high-quality production, but traditional synthesis methods can be slow and may not always meet stringent quality standards. Researchers need a reliable source for custom genes that adheres to GMP guidelines and delivers sequences rapidly.
Solution
NAGENE specializes in the rapid synthesis of custom DNA sequences, utilizing a GMP-compliant, in-house process to ensure high-quality production with an average turnaround time of five days. Their end-to-end solution covers all steps of the production process from enzymatic oligonucleotide synthesis to gene assembly. The company's innovative process allows them to efficiently produce both simple and highly complex genes, all in compliance with GMP standards.
Target Audience
NAGENE's primary customers are pharmaceutical researchers and developers, particularly those working on mRNA vaccines and cancer treatments, who require custom DNA sequences with fast turnaround times and GMP compliance.
Features
- Average turnaround time of 5 days for custom gene synthesis, including full plasmid sequencing.
- GMP-compliant, in-house production process ensuring high quality and reliability.
- End-to-end solution covering all steps from oligonucleotide synthesis to gene assembly.
- Capability to produce both simple and highly complex genes.
- Comprehensive quality control measures in accordance with ISO and GMP standards, including appearance, restriction digest, complete plasmid DNA sequencing (NGS), and more.
- Option for express production service for faster turnaround times on non-complex sequences.